Zwitterionic hydrogels for delivery of biomolecules

US12064534B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12064534-B2
Application numberUS-202217695964-A
CountryUS
Kind codeB2
Filing dateMar 16, 2022
Priority dateJul 8, 2014
Publication dateAug 20, 2024
Grant dateAug 20, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a novel approach in which zwitterionic networks are used to sequester and deliver ionic biomolecules, such as proteins, without compromising their native conformation and bioactivity. Zwitterionic networks are designed to effectively retain and deliver ionic or polar biomolecules for guided tissue regeneration. The invention represents a conceptual advance and enables a novel strategy for the utilization of zwitterionic motifs as therapeutics delivery vehicles and tissue engineering scaffolds.

First claim

Opening claim text (preview).

What is claimed is: 1. An implant consisting of a crosslinked 3-dimensioanl zwitterionic polymer and a protein, wherein the protein is encapsulated in the crosslinked 3-dimensional zwitterionic polymer and is characterized by preserved bioactivity as sequestered, wherein the crosslinked 3-dimensional zwitterionic polymer is polymethacrylate, polyacrylate, polymethacrylamide, or polyacrylamide crosslinked with poly (ethylene glycol) dimethacrylate, poly(ethylene glycol) diacrylate, ethylene glycol diacrylate, or ethylene glycol dimethacrylate. 2. The implant of claim 1 , wherein the protein is a therapeutic osteogenic protein. 3. The implant of claim 1 , wherein the protein is an anabolic agent. 4. The implant of claim 1 , wherein the protein is an angiogenic factor. 5. The implant of claim 1 , wherein the zwitterionic moiety comprises one or more selected from sulfobetaine, phosphorylcholine and carboxybetaine. 6. The implant of claim 5 , wherein the zwitterionic moiety is present in the polymer network as pendant groups to a polymeric backbone. 7. The impant of claim 6 , wherein the zwitterionic moiety is present in the polymer at a density from about 0.05 mol % to about 10 mol %. 8. The implant of claim 1 , wherein the polymer is characterized by a crosslinking density, from about 0.05 mol % to about 10 mol %. 9. The method of claim 1 , wherein the implant is biodegradable. 10. The implant of claim 1 , suitable for implant as a dental implant or bone implant.

Assignees

Inventors

Classifications

  • for reconstruction of bones; weight-bearing implants · CPC title

  • Hydrogels or hydrocolloids · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • Macromolecular materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12064534B2 cover?
The invention provides a novel approach in which zwitterionic networks are used to sequester and deliver ionic biomolecules, such as proteins, without compromising their native conformation and bioactivity. Zwitterionic networks are designed to effectively retain and deliver ionic or polar biomolecules for guided tissue regeneration. The invention represents a conceptual advance and enables a n…
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification A61K38/18. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).